Australian vaccine patent ruling shows tough new support requirements for life sciences innovators
Wyeth’s dispute with MSD underscores move towards stricter, UK-style disclosure obligations for IP rights
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.